To view this page ensure that Adobe Flash Player version 11.1.0 or greater is installed.
Ra dio l og y
Vacuum Device Offers Alternative to Surgery for Patients with
Potentially Deadly Clots
A minimally invasive procedure, used by
UCLA physicians for the first time in
California, uses a vacuum device to suck
potentially deadly blood clots out of a patient’s
heart. The device, AngioVac, represents an
important nonsurgical option to deal with
such life-threatening clots.
UCLA interventional radiologists and
surgeons used the AngioVac on a 62-year-old
patient who came to the emergency room
of Ronald Reagan UCLA Medical Center
complaining of shortness of breath, fatigue
How AngioVac Works
The AngioVac cannula is guided through
a vessel to the site of the clot and then
connected to a heart-bypass device
to create suction.
UCLAHEALTH.ORG 1-800-UCLA-MD1 (1-800-825-2631)
and extreme cold. A CT scan revealed a
24-inch clot that stretched from the patient’s
legs to his heart.
use of the device. He opted for the AngioVac,
and the clot was successfully removed. The
patient was able to return home within a week.
“The clot clogged his heart chamber like a wad
of gum in a pipe,” says John Moriarty, MD,
who performed the procedure. “Every moment
that passed increased the risk that the clot
would migrate to his lungs and kill him.”
To perform the AngioVac procedure,
interventional radiologists slide a tiny camera
down the patient’s esophagus to visually
monitor the heart, and then insert a tube
with a funnel-shaped tip into an artery in the
neck. The tube is guided through the blood
vessels until it reaches the clot. With one end
of the tube pressed against the clot, the other
end is threaded through a vein in the groin
Medication failed to break up the clot, leaving
the patient with a difficult choice: an open-
heart procedure that he might have been too
weak to endure or undergoing the first-time
Ra dio l og y
Vacuum Device Offers Alternative to Surgery for Patients with
Potentially Deadly Clots
A minimally invasive procedure, used by and extreme cold. A CT scan revealed a use of the device. He opted for the AngioVac,
UCLA physicians for the first time in 24-inch clot that stretched from the patient’s and the clot was successfully removed. The
California, uses a vacuum device to suck legs to his heart. patient was able to return home within a week.
potentially deadly blood clots out of a patient’s
“The clot clogged his heart chamber like a wad To perform the AngioVac procedure,
heart. The device, AngioVac, represents an
of gum in a pipe,” says John Moriarty, MD, interventional radiologists slide a tiny camera
important nonsurgical option to deal with
who performed the procedure. “Every moment down the patient’s esophagus to visually
such life-threatening clots.
that passed increased the risk that the clot monitor the heart, and then insert a tube
UCLA interventional radiologists and would migrate to his lungs and kill him.” with a funnel-shaped tip into an artery in the
surgeons used the AngioVac on a 62-year-old neck. The tube is guided through the blood
Medication failed to break up the clot, leaving
patient who came to the emergency room vessels until it reaches the clot. With one end
the patient with a difficult choice: an open-
of Ronald Reagan UCLA Medical Center of the tube pressed against the clot, the other
heart procedure that he might have been too
complaining of shortness of breath, fatigue end is threaded through a vein in the groin
weak to endure or undergoing the first-time
How AngioVac Works
The AngioVac cannula is guided through
a vessel to the site of the clot and then
connected to a heart-bypass device
to create suction.
UCLAHEALTH.ORG 1-800-UCLA-MD1 (1-800-825-2631)
Ra dio l og y
Vacuum Device Offers Alternative to Surgery for Patients with
Potentially Deadly Clots
A minimally invasive procedure, used by
UCLA physicians for the first time in
California, uses a vacuum device to suck
potentially deadly blood clots out of a patient’s
heart. The device, AngioVac, represents an
important nonsurgical option to deal with
such life-threatening clots.
UCLA interventional radiologists and
surgeons used the AngioVac on a 62-year-old
patient who came to the emergency room
of Ronald Reagan UCLA Medical Center
complaining of shortness of breath, fatigue
How AngioVac Works
The AngioVac cannula is guided through
a vessel to the site of the clot and then
connected to a heart-bypass device
to create suction.
UCLAHEALTH.ORG 1-800-UCLA-MD1 (1-800-825-2631)
and extreme cold. A CT scan revealed a
24-inch clot that stretched from the patient’s
legs to his heart.
use of the device. He opted for the AngioVac,
and the clot was successfully removed. The
patient was able to return home within a week.
“The clot clogged his heart chamber like a wad
of gum in a pipe,” says John Moriarty, MD,
who performed the procedure. “Every moment
that passed increased the risk that the clot
would migrate to his lungs and kill him.”
To perform the AngioVac procedure,
interventional radiologists slide a tiny camera
down the patient’s esophagus to visually
monitor the heart, and then insert a tube
with a funnel-shaped tip into an artery in the
neck. The tube is guided through the blood
vessels until it reaches the clot. With one end
of the tube pressed against the clot, the other
end is threaded through a vein in the groin
Medication failed to break up the clot, leaving
the patient with a difficult choice: an open-
heart procedure that he might have been too
weak to endure or undergoing the first-time